Document is current

Any future updates will be listed below

Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation

Crossref DOI link: https://doi.org/10.1186/s13014-017-0884-y

Published Online: 2017-09-07

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark